Sat.Dec 21, 2024 - Fri.Dec 27, 2024

article thumbnail

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacy of America

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

article thumbnail

Pain Management: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read pain management stories from the year 2024.

468
468
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: The DEA’s 2025 quotas for opioids will leave seriously ill patients in pain

STAT

A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.

145
145
article thumbnail

Nanoparticle drug delivery innovation could enhance drug development

European Pharmaceutical Review

Researchers in Australia have created an innovative drug delivery system that utilises a metalbiomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. As the MBN nanoparticles do not require complicated drug carriers and the materials are bio-compatible, the system has potential to boost successful drug development, according to first author Dr Wanjun Xu.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

2025 BCMTMS Exam – How To Prepare?

Med Ed 101

I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? – National Board of Medication Therapy Management Eligibility ASK EMPLOYER IF THEY WILL HELP PURCHASE STUDY MATERIALS AND TEST COSTS!!!! About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare?

103
103
article thumbnail

Neck Pain Management Crucial for Patients with Medication-Overuse Headache

Drug Topics

A study found that patients with medication-overuse headache and neck pain experience earlier onset of primary headache and decreased quality of life.

469
469

More Trending

article thumbnail

Merry Christmas!

OctariusRx

Merry Christmas! Thank you to our clients, family, and friends for all your support this year. Our entire team is grateful for our blessings and the wonderful people we work with. Whether you joined us this December, or have been with us for many years, thank you for allowing us to take care of you. We appreciate your trust and support. A successful year would be impossible without our hardworking team.

87
article thumbnail

FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes

Pharmacy Times

The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.

FDA 153
article thumbnail

Low Reimbursement, Coverage Restrictions Hinder Access to Vaccines

Drug Topics

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

Vaccines 469
article thumbnail

‘It’s absolutely open to abuse’: web awash with weight-loss drug offers

The Guardian - Pharmaceutical Industry

Readers describe aggressive online promotions, Black Friday deals and special offers for prescription-only drugs After Andy King was told he was not eligible to receive weight-loss jabs on the NHS, he turned to the internet to order them privately. But before long, he was inundated with promotions. Every other advert on my social media feed is an offer to have a Black Friday deal on the drugs, he said.

79
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Lawmakers call for curbs on UnitedHealth’s growing empire

STAT

Democratic lawmakers are calling for aggressive action to curb the increasing market power of UnitedHealth Group, including a possible breakup of a business empire they say is undermining competition, corrupting Medicare, and hurting vulnerable patients. The lawmakers, including several U.S. senators, argue the problems created by the company’s size and reach demand immediate steps to restore public confidence in the health care system.

Insurance 145
article thumbnail

Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis

Pharmacy Times

The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.

149
149
article thumbnail

Drug Topics: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read Drug Topics stories from the year 2024.

467
467
article thumbnail

Shrinking waistlines and growing profits: the weight-loss drug boom

The Guardian - Pharmaceutical Industry

Drugs such as Wegovy amd Mounjaro are an attractive prospect for online businesses and traditional pharmacies as well as the firms that make them It is a trend rooted in profit-making. Adverts featuring prescription-only weight-loss medications are splashed across the internet and it is causing concern among experts. But the question remains: who is driving the boom?

73
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Customized Medication for Chronic Pain

Compounding Pharmacy of America

Chronic pain is a pervasive condition that affects millions of individuals worldwide, impacting their daily activities, emotional well-being, and overall quality of life. Traditional pain management strategies, often relying on over-the-counter medications or standard prescriptions, can fall short in providing effective relief or avoiding undesirable side effects.

article thumbnail

Cholesterol-Metabolizing Bacteria May Potentially Benefit Lipid Homeostasis, Cardiovascular Health

Pharmacy Times

High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.

145
145
article thumbnail

COVID-19: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

460
460
article thumbnail

One in five Britons would use weight-loss drug if free on NHS, poll reveals

The Guardian - Pharmaceutical Industry

Survey also finds one in seven have either taken such jabs themselves or know someone who has One in five Britons would use a weight-loss drug if it was free on the NHS, according to polling that also shows one in seven have either taken a jab themselves or know someone who has. But almost one in four people would not tell others if they were using them, suggesting the growing popularity of weight-loss jabs is accompanied by persistent stigma about them.

69
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Generative AI in pharma: Moving beyond hype and into widespread adoption

pharmaphorum

Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.

124
124
article thumbnail

ASHP Midyear: Pharmacists Play Key Role in Comprehensive COPD Management, Emphasizing Cost Considerations

Pharmacy Times

Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.

139
139
article thumbnail

Cardiology: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read cardiology stories from the year 2024.

247
247
article thumbnail

STAT+: PhRMA dues fell almost $100 million as major drugmakers exited

STAT

WASHINGTON — Three large pharmaceutical companies left the brand-drug lobby PhRMA after the passage of Democrats’ drug pricing law in 2022. Following the exits, the organization collected $100 million less in annual membership dues, new tax filings show.

article thumbnail

Diversity in STEM in 2024: A reflection and a path forward

pharmaphorum

This article reflects on the current state of diversity in Science, Technology, Engineering, and Mathematics (STEM) fields in 2024 and outlines a path forward for creating a more inclusive and equitable environment.

113
113
article thumbnail

RECAP: 2024 Updates in the GLP-1 Space

Pharmacy Times

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.

article thumbnail

Digestive Health: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read digestive health stories from the year 2024.

247
247
article thumbnail

STAT+: As Congress waffles on AI, state legislatures step up to fill the void

STAT

State lawmakers are fed up with federal inaction on artificial intelligence and are taking matters into their own hands.  Lawmakers in Colorado, California, and Connecticut this year managed to pass AI-related bills, some quite sweeping in nature, even if the more ambitious ones were eventually killed by governors. And it’s not just blue states trying to fit guardrails onto the fast-moving AI industry.

120
120
article thumbnail

Being loud

pharmaphorum

Explore the concept of being loud in local, regional, and global life sciences with Oliver Stohlmann's Corporate Survival Hacks. Find practical tips and strategies to thrive in the industry.

111
111
article thumbnail

Mild IVIG-Related Adverse Events Are Frequent in Children, With Serious Reactions Possible

Pharmacy Times

Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.

139
139
article thumbnail

Total Pharmacy: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

247
247
article thumbnail

Novo gets the green light for once-daily haemophilia drug following setbacks 

Pharmaceutical Technology

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

FDA 105
article thumbnail

Amid BIOSECURE Act speculation, WuXi AppTec sells unit

pharmaphorum

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

105
105
article thumbnail

EPINEPHrine Nasal Solution, USP Recalled for Lack of Approval, Misbranding

Pharmacy Times

The nasal spray label resembles that of the FDA-approved epinephrine injection, leading to potential dosing errors.

Labelling 139
article thumbnail

Giving Pharmacists Prescriptive Authority for Glucagon Would Benefit Patients with Diabetes

Drug Topics

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.

247
247